Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023;99(2):357-371.
doi: 10.1080/09553002.2022.2074165. Epub 2022 May 26.

Low-dose radiotherapy for COVID-19 pneumonia and cancer: summary of a recent symposium and future perspectives

Mark P Little  1 , Wei Zhang  2 , Roy van Dusen  3 , Nobuyuki Hamada  4 , Michelle Bugden  5 , Meiyun Cao  5 , Kiersten Thomas  5 , Deyang Li  5 , Yi Wang  5   6 , Megha Chandrashekhar  5 , Mohammad K Khan  7 , C Norman Coleman  8
Affiliations

Low-dose radiotherapy for COVID-19 pneumonia and cancer: summary of a recent symposium and future perspectives

Mark P Little et al. Int J Radiat Biol. 2023.

Abstract

The lessons learned from the Coronavirus Disease 2019 (COVID-19) pandemic are numerous. Low dose radiotherapy (LDRT) was used in the pre-antibiotic era as treatment for bacterially/virally associated pneumonia. Motivated in part by these historic clinical and radiobiological data, LDRT for treatment of COVID-19-associated pneumonia was proposed in early 2020. Although there is a large body of epidemiological and experimental data pointing to effects such as cancer at low doses, there is some evidence of beneficial health effects at low doses. It has been hypothesized that low dose radiation could be combined with immune checkpoint therapy to treat cancer. We shall review here some of these old radiobiological and epidemiological data, as well as the newer data on low dose radiation and stimulated immune response and other relevant emerging data. The paper includes a summary of several oral presentations given in a Symposium on "Low dose RT for COVID and other inflammatory diseases" as part of the 67th Annual Meeting of the Radiation Research Society, held virtually 3-6 October 2021.

Keywords: COVID-19; Low dose radiotherapy; cancer risk; epidemiology; radiobiology.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

The authors declare no conflicts of interest.

References

    1. Ameri A, Ameri P, Rahnama N, Mokhtari M, Sedaghat M, Hadavand F, Bozorgmehr R, Haghighi M and Taghizadeh-Hesary F (2021). “Low-Dose Whole-Lung Irradiation for COVID-19 Pneumonia: Final Results of a Pilot Study.” Int J Radiat Oncol Biol Phys 109(4): 859–866. - PMC - PubMed
    1. Ameri A, Rahnama N, Bozorgmehr R, Mokhtari M, Farahbakhsh M, Nabavi M, Shoaei SD, Izadi H, Yousefi Kashi AS, Dehbaneh HS and Taghizadeh-Hesary F (2020). “Low-Dose Whole-Lung Irradiation for COVID-19 Pneumonia: Short Course Results.” Int J Radiat Oncol Biol Phys 108(5): 1134–1139. - PMC - PubMed
    1. Arenas M, Algara M, De Febrer G, Rubio C, Sanz X, de la Casa MA, Vasco C, Marín J, Fernández-Letón P, Villar J, Torres-Royo L, Villares P, Membrive I, Acosta J, López-Cano M, Araguas P, Quera J, Rodríguez-Tomás F and Montero A (2021). “Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial).” Strahlenther Onkol 197(11): 1010–1020. - PMC - PubMed
    1. Baylin GJ, Dubin IN and Gobbel WG Jr. (1946). “The effect of roentgen therapy on experimental virus pneumonia; on feline virus pneumonia.” Am J Roentgenol Radium Ther 55: 473–477. - PubMed
    1. Beecher HK (1955). “The powerful placebo.” J Am Med Assoc 159(17): 1602–1606. - PubMed

Publication types

LinkOut - more resources